Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Baumgartner

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytesD Heumann, P Gallay, C Barras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharideG Zanetti, D Heumann, J Gérain, et al.
The Journal of Infectious Diseases|May 1, 1990
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J D Baumgartner, G E Grau, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patientsA Cometta, J D Baumgartner, D Lew, et al.
Lancet (London, England)|July 13, 1985
Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipidJ D Baumgartner, M P Glauser, J A McCutchan, et al.
Critical Care Medicine|April 1, 1997
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumoniaI de Werra, C Jaccard, S B Corradin, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytesD Heumann, P Gallay, C Barras, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharideG Zanetti, D Heumann, J Gérain, et al.
The Journal of Infectious Diseases|May 1, 1990
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J D Baumgartner, G E Grau, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patientsA Cometta, J D Baumgartner, D Lew, et al.
Lancet (London, England)|July 13, 1985
Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipidJ D Baumgartner, M P Glauser, J A McCutchan, et al.
Critical Care Medicine|April 1, 1997
Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumoniaI de Werra, C Jaccard, S B Corradin, et al.
Pageof 6